MorphoSys AG Operating Expenses 2011-2026 | MOR

Annual Operating Expenses MorphoSys AG

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
432 M	450 M	656 M	301 M	168 M	137 M	134 M	110 M	93.4 M	69.8 M	68 M	49.5 M	81.6 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
656 M	49.5 M	211 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
AbbVie ABBV	12.8 B	$ 208.84	-2.86 %	$ 369 B	USA
AbCellera Biologics ABCL	292 M	$ 3.52	0.28 %	$ 1.05 B	Canada
Grifols, S.A. GRFS	1.64 B	$ 8.24	-0.12 %	$ 6.83 B	Spain
Ascendis Pharma A/S ASND	338 M	$ 229.25	0.44 %	$ 5 B	Danmark
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
ANI Pharmaceuticals ANIP	127 M	$ 74.21	-2.3 %	$ 1.43 B	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.41	2.17 %	$ 375 M	Britain
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Cocrystal Pharma COCP	9.02 M	$ 1.51	48.04 %	$ 17 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 55.5	-3.04 %	$ 10.6 B	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 8.03	2.29 %	$ 220 M	Israel
Adaptive Biotechnologies Corporation ADPT	141 M	$ 14.81	2.63 %	$ 2.25 B	USA
Altimmune ALT	94.5 M	$ 3.34	7.05 %	$ 294 M	USA
BioNTech SE BNTX	512 M	$ 91.18	1.97 %	$ 27.2 B	Germany
Amgen AMGN	9.33 B	$ 347.94	-1.51 %	$ 187 B	USA
Aurinia Pharmaceuticals AUPH	43.9 M	$ 15.61	0.9 %	$ 2.1 B	Canada
Bristol-Myers Squibb Company BMY	12.2 B	$ 59.6	-2.45 %	$ 121 B	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Burford Capital Limited BUR	106 M	$ 4.14	-2.59 %	$ 683 M	Britain
BioCryst Pharmaceuticals BCRX	144 M	$ 9.02	-3.84 %	$ 1.86 B	USA
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Atea Pharmaceuticals AVIR	181 M	$ 5.76	1.95 %	$ 469 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Cellectis S.A. CLLS	109 M	$ 3.41	1.19 %	$ 116 M	France
Biogen BIIB	5.39 B	$ 177.34	-3.5 %	$ 26 B	USA
Axcella Health AXLA	77 M	-	-16.42 %	$ 249 M	USA
Axon Enterprise AXON	1.18 B	$ 412.81	-2.54 %	$ 31.3 B	USA